158 related articles for article (PubMed ID: 35395364)
1. Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide.
MacEachern L; Kermanshahi-Pour A; Mirmehrabi M
Int J Pharm; 2022 May; 619():121723. PubMed ID: 35395364
[TBL] [Abstract][Full Text] [Related]
2. Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide.
Bettini R; Bonassi L; Castoro V; Rossi A; Zema L; Gazzaniga A; Giordano F
Eur J Pharm Sci; 2001 Jun; 13(3):281-6. PubMed ID: 11384850
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of a new solid form of praziquantel, an essential anthelmintic drug. Praziquantel racemic monohydrate.
Salazar-Rojas D; Maggio RM; Kaufman TS
Eur J Pharm Sci; 2020 Apr; 146():105267. PubMed ID: 32061654
[TBL] [Abstract][Full Text] [Related]
4. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
5. A new soluble and bioactive polymorph of praziquantel.
Zanolla D; Perissutti B; Passerini N; Chierotti MR; Hasa D; Voinovich D; Gigli L; Demitri N; Geremia S; Keiser J; Cerreia Vioglio P; Albertini B
Eur J Pharm Biopharm; 2018 Jun; 127():19-28. PubMed ID: 29409939
[TBL] [Abstract][Full Text] [Related]
6. Exploring mechanochemical parameters using a DoE approach: Crystal structure solution from synchrotron XRPD and characterization of a new praziquantel polymorph.
Zanolla D; Perissutti B; Vioglio PC; Chierotti MR; Gigli L; Demitri N; Passerini N; Albertini B; Franceschinis E; Keiser J; Voinovich D
Eur J Pharm Sci; 2019 Dec; 140():105084. PubMed ID: 31626966
[TBL] [Abstract][Full Text] [Related]
7. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.
Albertini B; Perissutti B; Bertoni S; Zanolla D; Franceschinis E; Voinovich D; Lombardo F; Keiser J; Passerini N
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870971
[TBL] [Abstract][Full Text] [Related]
8. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and transitions of sulfamerazine polymorphs.
Zhang GG; Gu C; Zell MT; Burkhardt RT; Munson EJ; Grant DJ
J Pharm Sci; 2002 Apr; 91(4):1089-100. PubMed ID: 11948548
[TBL] [Abstract][Full Text] [Related]
10. Crystal doping aided by rapid expansion of supercritical solutions.
Vemavarapu C; Mollan MJ; Needham TE
AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
[TBL] [Abstract][Full Text] [Related]
11. Solubility and precipitation of nicotinic acid in supercritical carbon dioxide.
Rehman M; Shekunov BY; York P; Colthorpe P
J Pharm Sci; 2001 Oct; 90(10):1570-82. PubMed ID: 11745715
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
Tong HH; Shekunov BY; York P; Chow AH
Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
[TBL] [Abstract][Full Text] [Related]
13. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H
Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical carbon dioxide and in vitro evaluation].
Liu H; Pan WS; Zhou LL; Zhang ZH
Yao Xue Xue Bao; 2007 Feb; 42(2):206-10. PubMed ID: 17518053
[TBL] [Abstract][Full Text] [Related]
15. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
16. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children.
Trastullo R; Dolci LS; Passerini N; Albertini B
Int J Pharm; 2015 Nov; 495(1):536-550. PubMed ID: 26386139
[TBL] [Abstract][Full Text] [Related]
17. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
20. The interplay between the paracetamol polymorphism and its molecular structures dissolved in supercritical CO2 in contact with the solid phase: In situ vibration spectroscopy and molecular dynamics simulation analysis.
Oparin RD; Moreau M; De Walle I; Paolantoni M; Idrissi A; Kiselev MG
Eur J Pharm Sci; 2015 Sep; 77():48-59. PubMed ID: 26028160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
